November 12, 2019
MEMPHIS, Tenn.–(BUSINESS WIRE)–In2Bones Global, Inc. today announces the commercial launch of the CoLink® Mini Plating System, a comprehensive, minimally invasive anatomic compression plating system used for fractures and fusions in the small bones of the foot.
Like all other products in In2Bones’ extensive platform of single-use implants for the hand and foot, the new system is packaged sterile for traceability and patient safety. 
Additional patient benefits include ultra-thin and low-profile plates. Minimal prominence at the plate and screw head interface provides protection against soft tissue irritation, which can occur with conventional trauma hardware.
For foot surgeons, there is nothing mini about this CoLink system. It delivers a greater range of choices for fracture and fusion applications. Multiple compression plate families are available in straight, oblique, and t-plate configurations in various lengths. Each plate accepts both 2.4 mm and 2.7 mm diameter screws, and, surgeons can choose either low profile or variable angle locking options.
The titanium plates are also type II anodized, providing a stronger, smoother surface compared to standard color anodization used in the manufacture of most other plates.
The CoLink Mini is the fifth plating system developed and marketed under the CoLink family brand. It demonstrates In2Bones’ commitment to expanding the extremities market with innovative implant designs and technological advancements that improve surgical outcomes and patient care.
For more information about In2Bones Global, Inc. extremity products, please visit www.In2Bones.com.
About In2Bones
Headquartered in Memphis, Tennessee, In2Bones is a global designer, manufacturer and distributor of medical devices for the treatment of disorders and injuries of the upper (hand, wrist, elbow) and lower (foot and ankle) extremities. For more information, visit www.i2b-usa.com.
Safe-Harbor Statement:
This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements made in this press release, other than statements of historical fact, are forward-looking statements. Forward-looking statements reflect management’s current view of future performance, results, and trends and may be identified by their use of terms such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “predict,” “will,” and other similar terms. The company wishes to caution readers that actual results might differ materially from those described in the forward-looking statements. Forward-looking statements are subject to a number of risks and uncertainties impacting the business, including increased competition, technical obsolescence, regulatory issues, general economic conditions and other risks.
Contacts
Media Contacts:
Jon Simon | Sr. Vice President of Marketing
In2Bones USA
6000 Poplar Ave, Suite 115 Memphis, TN 38119
O: 901.260.7931 • F: 844-712-6637
Email: jsimon@i2b-usa.com
https://www.linkedin.com/company/22344175/
Bob Reed
Element-R Partners
630.579.1770
bob@rurelevant.com